cGxP.wire https://validator.w3.org/feed/docs/rss2.html BioInvent Highlights BI-1206 NHL Combination Data at EHA BioInvent Reports Strong BI-1808 CTCL Responses at EHA Nurix Therapeutics Showcases Bexobrutideg Data at EHA Sana Biotechnology Advances In Vivo CAR T Platform AndzonBio2 and Cambridge Partner on Neuroinflammation Therapies Kelun-Biotech Gains China IND Clearance for SKB118 Renerva Implants First PNM-CAP Device for Neuroma Pain Innovent Highlights Obesity Pipeline at ADA 2026 Astellas Reports IZERVAY Reduced Vision Decline in GA Patients Exero Medical Highlights FDA Breakthrough xBar Study at ASCRS 2026 Ascentage Pharma Highlights Hematology Pipeline at EHA Andelyn Biosciences Earns ICMC Gene Therapy Certification DELFI Diagnostics Expands Blood-Based Lung Screening Cepheid Gains IVDR CE Mark for Xpert GI Panel AstraZeneca Reports Positive Phase III Results for Eneboparatide in HypoPT Isomorphic Labs Raises $2.1B for AI Drug Discovery Enliven Therapeutics Reports Strong ELVN-001 CML Data Pfizer Wins EU Approval for HYMPAVZI in Hemophilia Neurogene Highlights Rett Gene Therapy Progress at ASGCT Encoded Therapeutics Expands CNS Gene Therapy Pipeline Eli Lilly Strengthens GLP-1 Leadership With New Foundayo Trial Results Medicenna Advances MDNA11 Melanoma Trial in Italy AskBio Expands Rare Disease Pipeline With AB-1009 Pompe Trial Milestone AIRNA Showcases RNA Editing Advances at ASGCT 2026 Enlitic Expands AI Radiology Platform Into New Zealand Definium Therapeutics Begins Phase 3 DT120-ODT Study Boehringer Expands Immunology Pipeline With Immunitas Deal Tolion Health AI Expands Digital Brain Health With New AI Coach Castle Biosciences Wins 2026 Genomics Innovation Award BMS and Hengrui Form $15 Billion Drug Development Alliance Rigel Expands Oncology Portfolio With VEPPANU Licensing Deal Alkermes Reports Strong Phase 3 LUMRYZ Trial Data Mirai Bio Advances In Vivo CAR-T Platform at ASGCT Servier’s Emi-Le Earns FDA Breakthrough Status Novo Nordisk Expands Wegovy Leadership at ECO 2026 Hill’s and Bond Gain FDA Clearance for Pet Protein Merck Unveils Major Oncology Advances at ASCO 2026 Henlius Wins U.S. FDA IND Clearance for HLX05-N Roche Gains CE Mark Approval for Elecsys pTau217 Test Novo Nordisk Reports 28% Weight Loss With Higher-Dose Wegovy Caris Life Sciences Shows WES Improves Immunotherapy Survival Prediction Bristol Myers Squibb Secures EU Approval for Sotyktu in Psoriatic Arthritis PulseSight Reports Positive Phase 1 Results for PST-611 FDA Expands Drug Repurposing Initiative for Rare Diseases Encoded Therapeutics Reports Strong ETX101 Results aTyr Pharma Advances Efzofitimod Phase 3 Sarcoidosis Program Apnimed Highlights Phase 3 AD109 OSA Data at ATS 2026 Johnson & Johnson Showcases Neuropsychiatry Data at APA 2026 Dark Horse Consulting and KunTuo Partner to Accelerate CGT Trials Phio Pharmaceuticals Showcases PH-762 Skin Cancer Trial Progress